Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies

The adoptive transfer of chimeric antigen receptor T (CAR T) cells have been recognized as a promising therapeutic strategy for the treatment of hematological malignancies; however, clinical success using CAR T cells for the treatment of solid tumors are still limited since the T-cell function is in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shouheng, Cheng, Lin, Ye, Wei, Li, Shanglin, Zheng, Diwei, Qin, Le, Wu, Qiting, Long, Youguo, Lin, Simiao, Wang, Suna, Huang, Guohua, Li, Peng, Yao, Yao, Sun, Xiaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050336/
https://www.ncbi.nlm.nih.gov/pubmed/33868277
http://dx.doi.org/10.3389/fimmu.2021.642528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050336/
https://www.ncbi.nlm.nih.gov/pubmed/33868277
http://dx.doi.org/10.3389/fimmu.2021.642528

Ejemplares similares